EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Paul Hartmann AG's enterprise value is €809 Mil.
Paul Hartmann AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €2,353 Mil. Therefore, Paul Hartmann AG's EV-to-Revenue for today is 0.34.
The historical rank and industry rank for Paul Hartmann AG's EV-to-Revenue or its related term are showing as below:
FRA:PHH2'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.31 Med: 0.56 Max: 0.86
Current: 0.34
During the past 13 years, the highest EV-to-Revenue of Paul Hartmann AG was 0.86. The lowest was 0.31. And the median was 0.56.
FRA:PHH2's EV-to-Revenue is ranked better than 93.59% of 827
companies
in the Medical Devices & Instruments industry
Industry Median: 3.19
vs FRA:PHH2: 0.34
As of today (2024-05-15), Paul Hartmann AG's stock price is €200.00.
Paul Hartmann AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €662.61. Therefore, Paul Hartmann AG's PS Ratio for today is 0.30.
Paul Hartmann AG EV-to-Revenue Historical Data
The historical data trend for Paul Hartmann AG's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Paul Hartmann AG's EV-to-Revenue
For the Medical Instruments & Supplies subindustry, Paul Hartmann AG's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paul Hartmann AG's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Paul Hartmann AG's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Paul Hartmann AG's EV-to-Revenue falls into.
Paul Hartmann AG's current Enterprise Value is €809 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Paul Hartmann AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €2,353 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paul Hartmann AG (FRA:PHH2) EV-to-Revenue Explanation
Paul Hartmann AG's share price for today is €200.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was €662.61.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paul Hartmann AG EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Paul Hartmann AG's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compression therapy, first aid, immobilization, and diagnostics. The Incontinence segment provides incontinence hygiene, patient care, and medical skin care. The Infection segment consists of custom procedure trays, surgical draping systems, disposable surgical instruments, and disinfectants. The Other activities include activities in cotton-wool products, medical consumer goods and pharmaceutical products and others. All the activities are functioned through the region of US and derive revenue through the sale of medical and hygiene products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:PHH2 has been successfully added to your 